Coherus BioSciences, Inc. Profile Avatar - Palmy Investing

Coherus BioSciences, Inc.

Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the…

Biotechnology
US, Redwood City [HQ]
Strategy & Leadership

Mergers & Acquisitions Beta

M&A Deals · Breakdown

Coherus BioSciences, Inc. has no acquisition track records yet.

M&A Deals · History

Coherus BioSciences, Inc. has no acquisition track records yet.

End of CHRS's Analysis
CIK: 1512762 CUSIP: 19249H103 ISIN: US19249H1032 LEI: - UEI: -
Secondary Listings
CHRS has no secondary listings inside our databases.